With the continuous rise in tumor incidence, standardized diagnosis and treatment have become key to improving patient survival rates and quality of life. In recent years, new technologies, drugs, and personalized treatment plans have emerged in the field of oncology. However, challenges such as inconsistent diagnostic and treatment standards and insufficient multidisciplinary collaboration persist in clinical practice. There is a need to promote the standardization of diagnosis and treatment and the widespread application of innovative achievements through academic exchanges. To further enhance the level of tumor prevention and treatment and foster the deep integration of cutting-edge concepts with local practices, the Chengdu Hi-Tech Medical Association successfully held the "Immunotherapy 2.0 Era - Lung Cancer Symposium" in Chengdu on October 14, 2025.
The symposium focused on the latest clinical guidelines, the multidisciplinary team (MDT) model, precision medicine, translational research, and other trending topics in tumor diagnosis and treatment. Renowned experts were invited to deliver keynote presentations and share clinical case studies, aiming to build an academic exchange platform for clinicians, researchers, and medical institutions to jointly advance the standardized development of tumor diagnosis and treatment. This conference aimed to establish a high-level, practical platform for academic dialogue, bringing together collective wisdom and building consensus to jointly promote the standardized, precise, and innovative development of tumor diagnosis and treatment, particularly in the field of lung cancer. Leading national experts in oncology, especially those specializing in lung cancer diagnosis, treatment, and research, were invited to share keynote presentations and in-depth case studies. The content balanced forward-looking perspectives with practical applicability, striving to provide attendees with an academic feast that inspires thinking and guides practice.
The symposium targeted a wide range of clinical physicians, researchers, healthcare institution administrators, and other professionals involved in tumor prevention and treatment. Through in-depth exchanges and discussions, the conference aimed to:
Promote the broad awareness and unified application of standardized tumor diagnosis and treatment protocols.
Strengthen the concept of multidisciplinary collaborative diagnosis and treatment to enhance comprehensive clinical capabilities.
Accelerate the dissemination and optimization of innovative achievements, such as precision medicine, in clinical practice.
Establish a sustainable network for communication and collaboration, contributing to the overall improvement of tumor prevention and treatment at regional and national levels.
Gathering in Chengdu to discuss cutting-edge advancements, this academic conference focused on the standardized diagnosis, treatment, and future development of lung cancer. It aimed to unite efforts in enhancing the level of tumor prevention and treatment, contributing professional expertise to the "Healthy China" initiative.
